Pharmacology of Alpha-Receptor Antagonist Drugs - PowerPoint PPT Presentation

About This Presentation
Title:

Pharmacology of Alpha-Receptor Antagonist Drugs

Description:

Cardiovascular Effects -receptor antagonist drugs lower peripheral vascular resistance and blood pressure. These drugs can prevent the pressor effects of usual ... – PowerPoint PPT presentation

Number of Views:344
Avg rating:3.0/5.0
Slides: 21
Provided by: moha50
Category:

less

Transcript and Presenter's Notes

Title: Pharmacology of Alpha-Receptor Antagonist Drugs


1
Pharmacology of Alpha-Receptor Antagonist Drugs
  • Cardiovascular Effects
  • a -receptor antagonist drugs lower peripheral
    vascular resistance and blood pressure.
  • These drugs can prevent the pressor effects of
    usual doses of a agonists.

2
  • a -receptor antagonism converts the pressor
    response of epinephrine to a depressor response.

Epinephrine reversal is demonstrated by tracings
showing the response to epinephrine before
(middle) and after (bottom) phentolamine Top
tracing is Phentolamine .
3
  • Alpha-receptor antagonists cause orthostatic
    hypotension and reflex tachycardia.
  • Blockade of a 2-presynaptic receptors in the
    heart leads to augmented release of NE from
    peripheral sympathetic nerves, which will
    stimulate ß1 receptors in the heart leading to
    tachycardia and increased contractility of the
    heart.
  • Nonselective (a 1 a 2,) blockers usually cause
    significant tachycardia if blood pressure is
    lowered below normal.
  • Contraction of veins is an important component of
    the normal capacity to maintain blood pressure in
    the upright position since it decreases venous
    pooling in the periphery.

4
  • Other Effects
  • Miosis.
  • Nasal congestion.
  • Decreased resistance to the flow of urine. Alpha
    blockers, therefore, are used therapeutically for
    the treatment of urinary retention due to
    prostatic hyperplasia .

5
  • Phenoxybenzamine
  • Binds covalently(irreversibly) to a receptors,
    causing irreversible blockade of long duration
    (1448 hours or longer). It is somewhat selective
    for a 1 receptors but also blocks a 2 receptors.
  • The drug also inhibits reuptake of released NE
    and blocks histamine (H1),ACh, and serotonin
    receptors.
  • Causes relatively little fall in blood pressure
    in the supine position, it reduces blood pressure
    when sympathetic tone is high, e.g. in the
    upright posture.
  • Cardiac output may be increased because of
    reflex effects and because of some blockade of
    presynaptic a 2 receptors in cardiac sympathetic
    nerves.

6
  • Phenoxybenzamine is poorly absorbed after oral
    administration.
  • The major use of phenoxybenzamine is in the
    treatment of pheochromocytoma .
  • Adverse effects
  • Orthostatic hypotension and tachycardia. Nasal
    stuffiness and inhibition of ejaculation also
    occur.

7
  • Phentolamine
  • Potent competitive antagonist at a 1 and a 2
    receptors
  • Like phenoxybenzamine can cause orthostatic
    hypotension, tachycardia, increased heart
    contractility, and consequently increased cardiac
    output.

8
  • Phentolamine
  • Phentolamine also has minor inhibitory effects at
    serotonin receptors and agonist effects at
    muscarinic and H1 and H2 histamine receptors.
  • Phentolamine's principal adverse effects are
    related to cardiac stimulation, which may cause
    severe tachycardia, arrhythmias, and myocardial
    ischemia.
  • Phentolamine has been used in the treatment of
    pheochromocytoma.

9
  • Prazosin
  • Highly selective for a 1 receptors and typically
    1000-fold less potent at a 2 receptors.
  • This may partially explain the relative absence
    of tachycardia seen with prazosin compared with
    phentolamine phenoxybenzamine.
  • Relaxes both arterial and venous vascular smooth
    muscle, as well as smooth muscle in the prostate.

10
  • Terazosin
  • Reversible a 1-selective antagonist that is
    effective in hypertension.Also approved for use
    in men with urinary symptoms due to benign
    prostatic hyperplasia (BPH).
  • Terazosin has high bioavailability but is
    extensively metabolized in the liver, The
    half-life of terazosin is 912 hours.
  • Doxazosin
  • Efficacious in the treatment of hypertension and
    BPH.
  • Differs from prazosin and terazosin in having a
    longer half-life of about 22 hours.

11
  • Tamsulosin
  • Competitive a 1 antagonist with a structure quite
    different from that of most other a 1-receptor
    blockers.
  • High bioavailability and a half-life of 915
    hours.
  • Higher affinity for a 1A and a 1D receptors than
    for the a 1B subtype.
  • Has relatively greater potency in inhibiting
    contraction in prostate smooth muscle versus
    vascular smooth muscle compared with other a
    1-selective antagonists. a 1A subtype may be the
    most important a subtype mediating prostate
    smooth muscle contraction.
  • It is used to treat BPH.
  • Compared with other antagonists, tamsulosin has
    less effect on standing blood pressure in
    patients.

12
  • Drugs with Alpha- Adrenoceptor Antagonistic
    Activity
  • Labetalol
  • Has both a 1-selective and ß-antagonistic
    effects
  • Chlorpromazine and Haloperidol
  • Are potent dopamine receptor antagonists but are
    also antagonists at a receptors.
  • Useful antipsychotic drugs.
  • Their antagonism of a receptors probably
    contributes to some of their adverse effects,
    particularly hypotension.
  • Ergot derivatives
  • Ergotamine
  • Dihydroergotamine
  • Cause reversible a -receptor blockade,

13
(No Transcript)
14
  • Yohimbine
  • An indole alkaloid, a 2-selective antagonist.
  • Sometimes used in the treatment of orthostatic
    hypotension because it promotes norepinephrine
    release through blockade of presynaptic a 2
    receptors.
  • It was once widely used to improve male erectile
    dysfunction but has been superseded by
    phosphodiesterase-5 inhibitors like sildenafil
  • Yohimbine can reverse the antihypertensive
    effects of an a 2-adrenoceptor agonist such as
    clonidine.

15
  • Clinical Pharmacology of the Alpha-ReceptorBlocki
    ng Drugs
  • Pheochromocytoma is a tumor of the adrenal
    medulla or sympathetic ganglion cells. Patients
    have many symptoms and signs of catecholamine
    excess, including intermittent or sustained
    hypertension, headaches, palpitations, and
    increased sweating.
  • Phenoxybenzamine is given orally in the
    preoperative period to control hypertension.
  • It is also very useful in the chronic treatment
    of inoperable or metastatic pheochromocytoma.

16
  • Beta-receptor antagonists are required after a
    -receptor blockade to reverse the cardiac effects
    of excessive catecholamines.
  • Beta antagonists should not be used prior to
    establishing effective a -receptor blockade,
    since unopposed ß -receptor blockade could
    theoretically cause blood pressure elevation from
    increased vasoconstriction.
  • Metyrosine (a -methyltyrosine), a competitive
    inhibitor of tyrosine hydroxylase, is especially
    useful in symptomatic patients with inoperable or
    metastatic pheochromocytoma.
  • Because it has access to the central nervous
    system, metyrosine can cause extrapyramidal
    effects due to reduced dopamine levels

17
  • Hypertensive Emergencies
  • The a -adrenoceptor antagonist drugs have limited
    application in the management of hypertensive
    emergencies.
  • Labetalol has been used in Hypertensive
    Emergencies
  • In theory, a -adrenoceptor antagonists are most
    useful when increased blood pressure reflects
    excess circulating concentrations of agonists,
    eg, in pheochromocytoma, overdosage of
    sympathomimetic drugs, or clonidine withdrawal.

18
  • Chronic Hypertension
  • a 1-selective antagonists are efficacious drugs
    in the treatment of mild to moderate systemic
    hypertension.
  • They are generally well tolerated, but they are
    not usually recommended as monotherapy for
    hypertension because other classes of
    antihypertensives are more effective in
    preventing heart failure.
  • Their major adverse effect is orthostatic
    hypotension, which may be severe after the first
    few doses(First-Dose Phenomenon). They may cause
    dizziness.

19
  • Peripheral Vascular Disease
  • Alpha-receptorblocking drugs do not seem to be
    effective in the treatment of peripheral vascular
    occlusive disease characterized by morphologic
    changes that limit flow in the vessels.
  • Occasionally, individuals with Raynaud's
    phenomenon and other conditions involving
    excessive reversible vasospasm in the peripheral
    circulation do benefit from prazosin or
    phenoxybenzamine, although calcium channel
    blockers may be preferable for most patients.

20
  • Urinary Obstruction
  • Benign prostatic hyperplasia is common in elderly
    men.
  • a 1A-receptor antagonists have improved efficacy
    and safety in treating this disease.
  • The mechanism of action in improving urine flow
    involves partial reversal of smooth muscle
    contraction in the enlarged prostate and in the
    bladder base.
  • Prazosin, doxazosin, and terazosin are all
    efficacious in patients with BPH, but they also
    lower the blood pressure.
  • Tamsulosin is efficacious in BPH and has
    relatively minor effects on blood pressure at a
    low dose. This drug may be preferred in patients
    who have experienced orthostatic hypotension with
    other a 1-receptor antagonists.
Write a Comment
User Comments (0)
About PowerShow.com